Disease, Disability, and Injury Prevention and Control, 19970-19971 [E9-9948]
Download as PDF
<![CDATA[
19970
Federal Register / Vol. 74, No. 82 / Thursday, April 30, 2009 / Notices
Contact Person: Jonathan Arias, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170,
MSC 7840, Bethesda, MD 20892, 301–435–
2406, ariasj@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 20, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–9664 Filed 4–29–09; 8:45 am]
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Public Health
Research on Down Syndrome and
Interventions for Youth, Funding
Opportunity Announcement (FOA)
DD09–005; and Young Adults With
Fetal Alcohol Spectrum Disorders
(U84), FOA DD09–006, Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the aforementioned meeting.
Times and Dates:
1 p.m.–4 p.m., May 19, 2009 (Closed).
1 p.m.–4 p.m., May 20, 2009 (Closed).
1 p.m.–4 p.m., May 21, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Public Health Research on
Down Syndrome and Interventions for
Youth, FOA DD09–005; and Young Adults
with Fetal Alcohol Spectrum Disorders
(U84), FOA DD09–006.’’
Contact Person for More Information:
Geneva L. Cashaw, Designated Federal
Officer, CDC, 4770 Buford Highway, NE.,
Mailstop K92, Atlanta, GA 30341, Telephone
770–488–8294. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
Jkt 217001
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
15:35 Apr 29, 2009
Dated: April 24, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–9951 Filed 4–29–09; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 4140–01–M
VerDate Nov<24>2008
announcements of meetings and other
committee management activities, for both
CDC and the Agency for Toxic Substances
and Disease Registry.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention, announce the
following meeting for the
aforementioned subcommittee:
Time and Date: 11 a.m.–2 p.m., May 6,
2009
Place: Teleconference.
Status: Open to the public, but without a
public oral comment period. To access by
teleconference dial, 1(866)659–0537,
Participant Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2009.
Purpose: The Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
whether there is reasonable likelihood that
such radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
Reviews was established to aid the Advisory
Board in carrying out its duty to advise the
Secretary, HHS, on dose reconstruction.
Matters to be Discussed: The agenda for the
Subcommittee meeting includes preparation
of a letter report to the Secretary of Health
and Human Services on the first 100 dose
reconstruction cases reviewed; and the
review of the Board’s Case Selection Criteria
for dose reconstruction reviews.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
participate, written comments may be
submitted. Any written comments received
will be provided at the teleconference
meeting and should be submitted to the
contact person below in advance of the
teleconference meeting.
This teleconference meeting was scheduled
because the agenda items need to be
addressed by the Subcommittee prior to the
full Advisory Board meeting, which is
scheduled to convene on May 12, 2009.
Therefore, this Federal Register notice is
being published less than fifteen days prior
to the meeting date.
Contact Person for More Information:
Theodore Katz, Executive Secretary, NIOSH,
CDC, 1600 Clifton Road, NE., Mailstop E–20,
Atlanta, Georgia 30333, Telephone (513)
533–6800, Toll Free 1(800)CDC–INFO, E-mail
ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 24, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–9949 Filed 4–29–09; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control
Special Emphasis Panel (SEP): Impact
of Tic Disorders, including Tourette
Syndrome, in Youth, on Individuals,
Families and Communities (U01),
E:\FR\FM\30APN1.SGM
30APN1
Federal Register / Vol. 74, No. 82 / Thursday, April 30, 2009 / Notices
Funding Opportunity Announcement
(FOA) DD09–003; and Prevention of
Health Risk Behaviors among Youth
with Attention-Deficit/Hyperactivity
Disorder (U01), FOA DD09–004.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Times and Dates:
1 p.m.–4 p.m., May 14, 2009 (Closed).
1 p.m.–4 p.m., May 15, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘Impact of Tic Disorders,
including Tourette Syndrome, in Youth, on
Individuals, Families and Communities
(U01), FOA DD09–003; and Prevention of
Health Risk Behaviors among Youth with
Attention-Deficit/Hyperactivity Disorder
(U01), FOA DD09–004.’’
Contact Person for More Information:
Geneva L. Cashaw, Designated Federal
Officer, CDC, 4770 Buford Highway, NE.,
Mailstop K92, Atlanta, GA 30341, Telephone
770–488–8294.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 24, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–9948 Filed 4–29–09; 8:45 am]
individuals associated with the grant
applications, the disclosure of which
would constitute clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel Loan Repayment Applications.
Date: May 11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3AN18, 45 Center
Drive, Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Margaret J. Weidman, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18B, Bethesda, MD
20892, 301–594–3663,
weidmanmanigms.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93375, Minority Biomedical
Research Support; 93821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: April 21, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–9661 Filed 4–29–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4163–18–P
National Institute of General Medical
Sciences; Notice of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory General Medical
Sciences Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
VerDate Nov<24>2008
15:35 Apr 29, 2009
Jkt 217001
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
19971
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: May 21–22, 2009.
Closed: May 21, 2009, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Open: May 22, 2009, 8 a.m. to
adjournment.
Agenda: For the discussion of program
policies and issues, opening remarks, report
of the Director, NIGMS, and other business
of the Council.
Place: National Institutes of Health,
Natcher Bulidinig, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Ann A. Hagan, PhD,
Associate Director for Extramural Activities,
NIGMS, NIH, DHHS, 45 Center Drive, Room
2AN24H MSC6200, Bethesda, MD 20892–
6200. (301) 594–4499.
hagana@nigms.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
http:/www.nigms.nih.gov/about/
advisory_council.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: April 21, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–9663 Filed 4–29–09; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\30APN1.SGM
30APN1
]]>Agencies
[Federal Register Volume 74, Number 82 (Thursday, April 30, 2009)]
[Notices]
[Pages 19970-19971]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9948]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Impact of Tic Disorders, including
Tourette Syndrome, in Youth, on Individuals, Families and Communities
(U01),
[[Page 19971]]
Funding Opportunity Announcement (FOA) DD09-003; and Prevention of
Health Risk Behaviors among Youth with Attention-Deficit/Hyperactivity
Disorder (U01), FOA DD09-004.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Times and Dates:
1 p.m.-4 p.m., May 14, 2009 (Closed).
1 p.m.-4 p.m., May 15, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
``Impact of Tic Disorders, including Tourette Syndrome, in Youth, on
Individuals, Families and Communities (U01), FOA DD09-003; and
Prevention of Health Risk Behaviors among Youth with Attention-
Deficit/Hyperactivity Disorder (U01), FOA DD09-004.''
Contact Person for More Information: Geneva L. Cashaw,
Designated Federal Officer, CDC, 4770 Buford Highway, NE., Mailstop
K92, Atlanta, GA 30341, Telephone 770-488-8294.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: April 24, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-9948 Filed 4-29-09; 8:45 am]
BILLING CODE 4163-18-P
